Canada
· Delayed Price · Currency is CAD WELL Health Technologies Statistics
Total Valuation
WELL Health Technologies has a market cap or net worth of CAD 1.77 billion. The enterprise value is 2.17 billion.
| Market Cap | 1.77B |
| Enterprise Value | 2.17B |
Important Dates
The next estimated earnings date is Tuesday, March 25, 2025.
| Earnings Date | Mar 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
WELL Health Technologies has 249.02 million shares outstanding. The number of shares has increased by 7.35% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 249.02M |
| Shares Change (YoY) | +7.35% |
| Shares Change (QoQ) | -5.27% |
| Owned by Insiders (%) | 22.83% |
| Owned by Institutions (%) | 4.43% |
| Float | 192.18M |
Valuation Ratios
The trailing PE ratio is 23.65 and the forward PE ratio is 229.03. WELL Health Technologies's PEG ratio is 9.16.
| PE Ratio | 23.65 |
| Forward PE | 229.03 |
| PS Ratio | 1.81 |
| PB Ratio | 2.09 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 15.77 |
| P/OCF Ratio | n/a |
| PEG Ratio | 9.16 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.62, with an EV/FCF ratio of 19.35.
| EV / Earnings | 29.54 |
| EV / Sales | 2.27 |
| EV / EBITDA | 17.62 |
| EV / EBIT | 39.43 |
| EV / FCF | 19.35 |
Financial Position
The company has a current ratio of 1.14, with a Debt / Equity ratio of 0.43.
| Current Ratio | 1.14 |
| Quick Ratio | 1.02 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | 3.15 |
| Debt / FCF | 3.54 |
| Interest Coverage | 1.55 |
Financial Efficiency
Return on equity (ROE) is 10.89% and return on invested capital (ROIC) is 2.85%.
| Return on Equity (ROE) | 10.89% |
| Return on Assets (ROA) | 2.45% |
| Return on Capital (ROIC) | 2.85% |
| Revenue Per Employee | 635,497 |
| Profits Per Employee | 48,723 |
| Employee Count | 1,507 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 328.00 |
Taxes
In the past 12 months, WELL Health Technologies has paid 2.49 million in taxes.
| Income Tax | 2.49M |
| Effective Tax Rate | 7.78% |
Stock Price Statistics
The stock price has increased by +82.52% in the last 52 weeks. The beta is 1.20, so WELL Health Technologies's price volatility has been higher than the market average.
| Beta (5Y) | 1.20 |
| 52-Week Price Change | +82.52% |
| 50-Day Moving Average | 5.40 |
| 200-Day Moving Average | 4.49 |
| Relative Strength Index (RSI) | 76.14 |
| Average Volume (20 Days) | 1,737,051 |
Short Selling Information
The latest short interest is 1.51 million, so 0.61% of the outstanding shares have been sold short.
| Short Interest | 1.51M |
| Short Previous Month | 1.42M |
| Short % of Shares Out | 0.61% |
| Short % of Float | 0.67% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, WELL Health Technologies had revenue of CAD 957.69 million and earned 73.43 million in profits. Earnings per share was 0.30.
| Revenue | 957.69M |
| Gross Profit | 422.89M |
| Operating Income | 57.83M |
| Pretax Income | 94.34M |
| Net Income | 73.43M |
| EBITDA | 115.37M |
| EBIT | 57.83M |
| Earnings Per Share (EPS) | 0.30 |
Balance Sheet
The company has 66.15 million in cash and 396.37 million in debt, giving a net cash position of -330.22 million or -1.33 per share.
| Cash & Cash Equivalents | 66.15M |
| Total Debt | 396.37M |
| Net Cash | -330.22M |
| Net Cash Per Share | -1.33 |
| Equity (Book Value) | 918.03M |
| Book Value Per Share | 3.40 |
| Working Capital | 37.76M |
Cash Flow
In the last 12 months, operating cash flow was 126.81 million and capital expenditures -14.69 million, giving a free cash flow of 112.12 million.
| Operating Cash Flow | 126.81M |
| Capital Expenditures | -14.69M |
| Free Cash Flow | 112.12M |
| FCF Per Share | 0.45 |
Margins
Gross margin is 44.16%, with operating and profit margins of 6.04% and 7.67%.
| Gross Margin | 44.16% |
| Operating Margin | 6.04% |
| Pretax Margin | 9.85% |
| Profit Margin | 7.67% |
| EBITDA Margin | 12.05% |
| EBIT Margin | 6.04% |
| FCF Margin | 11.71% |
Dividends & Yields
WELL Health Technologies does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.35% |
| Shareholder Yield | -7.35% |
| Earnings Yield | 4.23% |
| FCF Yield | 6.34% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
WELL Health Technologies has an Altman Z-Score of 1.61 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.61 |
| Piotroski F-Score | 6 |